Salivary glycan profiles could be good markers for discriminating diabetic nephropathy from non-diabetic renal disease

A group from Department of Nephrology, The First Medical Centre, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center of Kidney Diseases, Beijing Key Laboratory of Kidney Disease, Beijing, China, etc. has reported that salivary glycan profiles could be good markers for discriminating diabetic nephropathy (DN) from non-diabetic renal disease (NDRD).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9009518/

Glycan profiles in the saliva could be a non-invasive tool for distinguishing between DN and NDRD.

The AAL, LEL, LCA, VVA, and NPA levels could reflect the severity of DN, and

the LEL and LCA levels could indicate the prognosis of DN.